Alison Malloy
Managing Director, Investments @ Connecticut Innovations
Alison Malloy is a Series B investor at Connecticut Innovations focused on SaaS and Security. Alison Malloy is the Managing Director, Investments at Connecticut Innovations.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Alison Malloy invests in
Stages Alison Malloy invests in
Countries Alison Malloy invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- SaaS 1 (33%)
- Security 1 (33%)
- Biometrics 1 (33%)
- Cyber Security 1 (33%)
- Machine Learning 1 (33%)
Stage
- Series B 2 (67%)
- Series C 1 (33%)
Country
- India 1 (33%)
- Canada 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Invixium is a leading global provider of touchless biometric solutions that utilize face recognition and temperature detection for access control, workforce management, and visitor screening. Invixium’s fully integrated hardware and software solution provides meaningful analytics to enterprises and industries for increased safety, health, securityand productivity.During these unprecedented times, the security of organizations and the health of employees are ever so important. As countries ease lockdowns and plan for a return to the workplace, Invixium has been hard at work developing solutions to solve real-world problems at a rapid pace. By focusing on touchless biometric solutions that ensure the safety and security of the enterprise as well as the employee’s peace of mind; and by implementing technologies like fever detection, Invixium is leading the change into the new world of access control and workforce management. Our razor-sharp focus on enhancing the customer experience has driven us to devote countless hours to perfect our enterprise-grade software platform – IXM WEB. With intuitive workflows and data-driven dashboards, the software provides a comprehensive summary and health of your biometric system. Innovative features within the software, including IXM Time, Health, Link, Convert, and Translate, are designed to optimize enterprises’ access control or workforce management systems to be more efficient and productive.Invixium’s management team has a combined experience of more than 200 years in the biometric access control industry. This extensive experience manifests itself in everything that we have to offer. Invixium’s solutions have been deployed by major enterprises and industries across a broad spectrum of verticals including government, banking, healthcare, pharmaceuticals, refineries, seaports, mining, and higher education in over 60 countries. Invixium products are proudly Made in Canada. | $3M / Series C / Jun 08, 2020 | ||
| Invixium is a leading global provider of touchless biometric solutions that utilize face recognition and temperature detection for access control, workforce management, and visitor screening. Invixium’s fully integrated hardware and software solution provides meaningful analytics to enterprises and industries for increased safety, health, securityand productivity.During these unprecedented times, the security of organizations and the health of employees are ever so important. As countries ease lockdowns and plan for a return to the workplace, Invixium has been hard at work developing solutions to solve real-world problems at a rapid pace. By focusing on touchless biometric solutions that ensure the safety and security of the enterprise as well as the employee’s peace of mind; and by implementing technologies like fever detection, Invixium is leading the change into the new world of access control and workforce management. Our razor-sharp focus on enhancing the customer experience has driven us to devote countless hours to perfect our enterprise-grade software platform – IXM WEB. With intuitive workflows and data-driven dashboards, the software provides a comprehensive summary and health of your biometric system. Innovative features within the software, including IXM Time, Health, Link, Convert, and Translate, are designed to optimize enterprises’ access control or workforce management systems to be more efficient and productive.Invixium’s management team has a combined experience of more than 200 years in the biometric access control industry. This extensive experience manifests itself in everything that we have to offer. Invixium’s solutions have been deployed by major enterprises and industries across a broad spectrum of verticals including government, banking, healthcare, pharmaceuticals, refineries, seaports, mining, and higher education in over 60 countries. Invixium products are proudly Made in Canada. | $665K / Series B / May 21, 2019 | ||
| CloudSEK provides AI-driven cybersecurity solutions that help organizations identify, monitor, and respond to digital risks and external threats. Its platform uses contextual artificial intelligence to scan a wide range of online sources, offering insights into data leaks, brand impersonation, exposed infrastructure, and supply chainvulnerabilities. CloudSEK’s suite includes tools for digital risk protection, attack surface monitoring, supply chain risk tracking, and proactive threat intelligence alerts that support security teams in prioritizing and addressing potential issues. The technology correlates threat data across surface web, deep web, and dark web signals to give contextualized alerts and visibility into an organization’s external attack surface. CloudSEK also supports integration of its threat insights into existing security systems to streamline risk management workflows. | $10M / Series B |
Co-Investors
About Connecticut Innovations
guidance and introductions to valuable partners, Connecticut innovations enable promising businesses to thrive.
Connecticut Innovations Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alison Malloy
Managing Director, Investments
|
|||
Matthew D. Storeygard
Managing Director, Venture Capital Investments
|
|||
Dan Devine
Regenerative Medicine Research Fund Advisory Committee Member
|
|||
Daniel Wagner
Sr. Managing Director, Investments
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Alison Malloy invest in?
Alison Malloy invests primarily in SaaS, Security and Biometrics startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alison Malloy?
Public channels for Alison Malloy include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alison Malloy last invest?
The most recent investment recorded for Alison Malloy closed in Jun 2020. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
